Oakland, CA, United States of America

Joane Litvak



 

Average Co-Inventor Count = 7.1

ph-index = 9

Forward Citations = 202(Granted Patents)


Company Filing History:


Years Active: 1997-2017

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: **Joane Litvak: Innovator in Pharmaceutical Research**

Introduction

Joane Litvak is a notable inventor based in Oakland, CA, whose contributions to the field of pharmaceuticals have led to the granting of 22 patents. His innovative work focuses on developing compounds that target specific receptor protein tyrosine kinases, particularly Axl, which is implicated in various diseases.

Latest Patents

Among his latest patents, Joane has developed N-Heteroaryl and bridged bicyclic aryl substituted triazoles. These compounds and their pharmaceutical compositions are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Furthermore, methods for utilizing these compounds to treat diseases or conditions associated with Axl activity are outlined in his patents.

Career Highlights

Throughout his career, Joane has worked with prominent companies in the biotech and pharmaceutical industries, including Rigel Pharmaceuticals and Axys Pharmaceuticals. His work in these organizations illustrates a commitment to advancing pharmaceutical research and addressing unmet medical needs.

Collaborations

Joane has collaborated with several notable professionals in the field, including Dane A Goff and Jing Zhang. These partnerships have contributed to the successful development of new compounds and therapeutic strategies that hold the potential to make significant impacts on healthcare.

Conclusion

Joane Litvak's dedication to innovation in the pharmaceutical domain is evident through his extensive patent portfolio and successful collaborations. His work in targeting Axl activity offers promising avenues for the treatment of various conditions, showcasing the vital role that inventors play in the continual advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…